MuseGlobal Creates Customized Connections to the Elsevier XML Gateway

MuseGlobal Creates Customized Connections to the Elsevier XML Gateway

Salt Lake City, December 11, 2006 -- MuseGlobal Inc. and Elsevier today announced the deployment of two new Muse Source Packages to the Elsevier XML Gateway, enabling users to search more information in less time with greater efficiency.

Muse Source Packages allow Scopus and ScienceDirect customers to search and retrieve information from multiple sources simultaneously while accessing Elsevier’s high-quality content. In addition, they give customers a more stable connection to the Elsevier XML Gateway and better functionality. Scopus is a navigation tool covering the world's largest collection of abstracts, references and indexes of scientific, technical and medical (STM) information. ScienceDirect is a platform that offers more than a quarter of the world’s STM information online.

Amanda Spiteri, Marketing Director, ScienceDirect, explained: "The MuseGlobal partnership will enhance existing metasearch capabilities with improved technology and allow ScienceDirect and Scopus customers to search our content in our native environment (from a single interface). It will also provide Elsevier with the highest level of authentication and monitoring details available."

"Elsevier was keen to provide their customers with a complete metasearch experience, and they developed the XML Gateway specifically for Scopus and ScienceDirect," stated Graeme Wilson, VP Partner Program, MuseGlobal.

MuseGlobal worked closely with Elsevier technical staff and the new Source Packages underwent extensive testing to guarantee a stable pre-release. Both companies will work directly with their customers to set up the appropriate user IDs and logons required to achieve optimum performance from the XML Gateway Source Package.

###

About Scopus
Scopus was designed and developed with over 300 users and librarians internationally. Its unique database contains abstracts and references from over 14,000 titles from 4,000 different publishers, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers citation information about the articles covered, but also integrates Web and patent searches directly from its clean and simple interface. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool. For more information about Scopus please visit www.info.scopus.com.

About ScienceDirect
Over a quarter of the world's full text scientific, technical and medical (STM) articles – managed by renowned editors, written by respected authors and read by researchers from around the globe – are available in one place: ScienceDirect.

Elsevier’s extensive and unique full-text collection covers authoritative titles from the core scientific literature including high impact factor titles such as THE LANCET, Cell and Tetrahedron. Over seven-and-a-half million articles are available online, including Articles in Press which offer rapid access to recently accepted manuscripts. The critical mass of information available on ScienceDirect is unsurpassed. Coverage includes over 2000 journals published by Elsevier and dynamic linking to journals from approximately 350 STM publishers through CrossRef. An expanding program of online major reference works, handbooks and book series in all fields of science seamlessly interlinks with primary research referenced in journal articles.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact
Benjamin Clark
ScienceDirect
+31 20 485-2713
b.clark@elsevier.com